# CVI Drug Coated Balloon First In Human Trial

> **NCT02110524** · NA · COMPLETED · sponsor: **Spectranetics Corporation** · enrollment: 80 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** Percutaneous Transluminal Angioplasty

## Key facts

- **NCT ID:** NCT02110524
- **Lead sponsor:** Spectranetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-09
- **Final completion:** 2014-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2015-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02110524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02110524, "CVI Drug Coated Balloon First In Human Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02110524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*